home / stock / evo / evo news


EVO News and Press, Evotec SE

Stock Information

Company Name: Evotec SE
Stock Symbol: EVO
Market: NASDAQ
Website: evotec.com

Menu

EVO EVO Quote EVO Short EVO News EVO Articles EVO Message Board
Get EVO Alerts

News, Short Squeeze, Breakout and More Instantly...

EVO - Pfizer, Evotec ink drug discovery deal

2024-07-10 07:09:08 ET More on Evotec SE, Evotec SE, etc. The Next Paxlovid Pfizer: Buy This Big Yielder On The Strong Pipeline Pfizer: The Inflection Point Is Here Pfizer R&D head Mikael Dolsten to depart Executive reshuffles: NIO, Pfizer and Spi...

EVO - Evotec and Pfizer Collaborate to Advance Drug Discovery in France

Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases HAMBURG, GERMANY / ACCESSWIRE / July 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(NASDAQ:EVO) (MDAX/TecDAX , ISIN: DE0005664809) today announced it has entered into a mul...

EVO - Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars Additional biosimilars potentially to be added to Sandoz development pipeline Further guarantees for Sandoz long-term commercial supply security HAMBURG, GERMANY...

EVO - Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...

EVO - Evotec gains after report on potential takeovers

2024-06-20 07:35:13 ET More on Evotec SE Evotec SE (EVO) Q1 2024 Earnings Call Transcript Evotec SE 2024 Q1 - Results - Earnings Call Presentation Evotec SE (EVO) Q4 2023 Earnings Call Transcript Evotec to exit gene therapy business, close Austria site ...

EVO - Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb

Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / June 12, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/T...

EVO - Evotec SE: Results of the Annual General Meeting 2024

Most agenda items adopted with great majority Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka HAMBURG, GERMANY / ACCESSWIRE / June 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDA...

EVO - Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases

Partnership will expand Evotec's molecular patient database in the area of metabolic diseases and in particular obesity Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics Lille Univers...

EVO - Harding Loevner International Small Companies Equity Composite Q1 2024 Report

2024-05-29 12:45:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

EVO - Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington's Disease

Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington's disease One of Evotec's largest strategic drug discovery alliances HAMBURG, GERMANY / ACCESSWIRE / May 28, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE000...

Next 10